Stocks of Rigel Pharmaceuticals (NASDAQ:RIGL) traded higher last session on Wall Street, down -6.24% to $0.79.
RIGL stock price is now -21.98% away from the 50-day moving average and -30.60% away from the 200-day moving average. The market capitalization of the company currently stands at $138.59M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
, while ‘Piper Sandler’ rates the stock as ‘Neutral’
In other news, RODRIGUEZ RAUL R, CEO, President sold 30,545 shares of the company’s stock on Feb 05 ’24. The stock was sold for $34,821 at an average price of $1.14. Upon completion of the transaction, the CEO, President now directly owns 2,036,629 shares in the company, valued at $1.61 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 05 ’24, EVP, Chief Commercial Officer Santos David A sold 8,918 shares of the business’s stock. A total of $10,167 was realized by selling the stock at an average price of $1.14. This leaves the insider owning 349,093 shares of the company worth $0.28 million. A total of 1.99% of the company’s stock is owned by insiders.
During the past 12 months, Rigel Pharmaceuticals has had a low of $0.71 and a high of $1.73. The fifty day moving average price for RIGL is $1.0052 and a two-hundred day moving average price translates $1.137 for the stock.
The latest earnings results from Rigel Pharmaceuticals (NASDAQ: RIGL) was released for 2024-03-31. The company reported revenue of $29.53 million for the quarter, compared to $26.07 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.29 percent.
